DOCSLIB.ORG

Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Archives of Disease in Childhood, 1987, 62, 385-391 Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency H A SIMMONDS, L D FAIRBANKS, G S MORRIS, G MORGAN, A R WATSON, P TIMMS, AND B SINGH Purine Laboratory, Guy's Hospital, London, Department of Immunology, Institute of Child Health, London, Department of Paediatrics, City Hospital, Nottingham, Department of Paediatrics and Chemical Pathology, National Guard King Khalid Hospital, Jeddah, Saudi Arabia SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders that the two major clinical consequences of complete PNP deficiency have differing indicates copyright. aetiologies: (1) neurological effects resulting from deficiency of the PNP enzyme products, which are the substrates for HGPRT, leading to functional deficiency of this enzyme. (2) immunodeficiency caused by accumulation of the PNP enzyme substrates, one of which, deoxyguanosine, is toxic to T cells. These studies show the need to consider PNP deficiency (suggested by the finding of hypouricaemia) in patients with neurological dysfunction, as well as in T cell immunodeficiency. http://adc.bmj.com/ They suggest an important role for GTP in normal central nervous system function. Deficiency of the enzyme purine nucleoside phos- findings in our latest case of PNP deficiency with phorylase (PNP:EC 2.4.2.1) was first reported in those in two previous kindreds5 9 and highlights 1975 in a child with recurrent infection and severe developmental retardation as a prominent on September 29, 2021 by guest. Protected anaemia.' Clinical features in the first nine cases2-4 clinical feature of the disorder. We have also found have invariably been related to a pronounced severe guanosine triphosphate (GTP) depletion in reduction in T cell numbers and function, with the red cells of all available homozygotes from these either normal or enhanced B cell function.17 kindreds,5 9 1lin addition to the dGTP accumula- Deoxyguanosine triphosphate (dGTP) has been tion noted earlier by others.2-4 As the brain has a found in the erythrocytes and implicated in the T high requirement for GTP 12 and resembles the cell dysfunction of the disorder.2-5 The age at human erythrocyte (Fig. 1) in being largely depen- presentation has varied from birth to 6 years. dent on salvage to maintain GTP concentrations the Therapeutic approaches to restore immune com- combined clinical and biochemical findings support petence have usually been unsuccessful.2-5 Most a direct relation between the enzyme defect and the patients have died from viral infection or neurological dysfunction. They underline the fact lymphoma. 1-9 Successful engraftment after haploid- that PNP deficiency should be suspected in children entical bone marrow transplantation has been with central nervous system (CNS) disorders as well reported recently in a single case.") as T cell immunodeficiency and suggest a metabolic This paper compares clinical and biochemical basis for this association. 385 Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from 386 Simmonds, Fairbanks, Morris, Morgan, Watson, Timms, and Singh DNA ; d-Guanosine dGDP GDP ADP d-Adenosine d- Adenosine dGMP G MP IMP * AMP d-lnosine d-Guanosine Guanosine I Inosine Adenosinev_ VE<L>eAvr|~~~~~IY M)XI Plasman ' S, ,fl s , d-Inosine d-Guanosine Guanosine Inosine Urine Fig. 1 Pathways of purine metabolism, indicating the importance of PNP for the degradation of deoxyribonucleosides derived from the turnover of DNA, as well as ribonucleosides arising from A TP and GTP (all shown in bold) during daily cell turnover. In the absence of PNP (broken arrows) the four PNP substrates indicated accumulate in the plasma and are excreted in urine in place of uric acid. The potential for dGTP formation after deoxyguanosine accumulation when PNP is defective is also shown. The effect of complete PNP deficiency in restricting substrate availability for HGPRT is evident from the broken line, copyright. showing that HGPRT normally plays a vital role in tandem with PNP for guanine recycling and maintenance of GTP concentrations, particularly when de novo synthesis is absent, as in the human erythrocyte, or limited, as in the brain. The importance of extracellular adenosine, and hence adenosine kinase, for maintaining A TP concentrations in the red cell, due to a lack of the normal route of A TP formation from IMP present in nucleated cells, is also indicated. PNP=Purine nucleoside phosphorylase; DNA=deoxyribonucleic acid; ATP=adenosine triphosphate; ADP=adenosine diphosphate; AMP= adenosine monophosphate; GTP=guanosine triphosphate; GDP=guanosine diphosphate; GMP=guanosine monophosphate; dGTP=deoxyguanosine triphosphate; dGDP=deoxyguanosine diphosphate; dGMP- deoxyguanosine monophosphate; HGPRT=hypoxanthine-guanine phosphoribosyltransferase; IMP=inosine http://adc.bmj.com/ monophosphate; d-=deoxy. Patients and methods the progressive immunodeficiency.5 Excessive head lag and irritability were noticeable by 3 months. Case reports. Extensive neurological investigation revealed no Family I organic lesion or viral infection. The infant there- The propositus (case 1) in this family was the first after remained profoundly hypotonic with develop- on September 29, 2021 by guest. Protected son of healthy Irish parents who were fourth mental delay in all spheres. Hypertonicity of the cousins. A full clinical history has been reported.8 In lower limbs developed before his death at 2 years brief, the infant had considerable developmental from an acute para-influenza type 111 infection with delay before an aseptic meningitis at 2 years, from pneumonia. There was no structural brain lesion at which he made a full recovery. At 2 years 8 months postmortem examination. he presented with an illness similar to glandular fever. He was unable to walk unsupported and had a Family 2 crude hand grasp and delayed speech. A spastic The propositus (case 3) was an Arab girl, the sixth tetraparesis was clinically evident. He died of child of parents who were first cousins. Full details malignant lymphoma of the immunoblastic type are given elsewhere.9 She presented with anaemia of shortly after PNP deficiency was defined. seven days' duration at 4 years in January 1985. A A second boy (case 2) was born in June 1980 and spastic tetraparesis was noted. Developmental delay PNP deficiency was confirmed at birth. He was kept was first investigated at 1 year. General physical under close clinical observation while different examination showed hypertonia and exaggerated treatments were given in an attempt to ameliorate tendon reflexes, involving all limbs. An intention Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Central nervous system dysfunction in purine nucleoside phosphorylase deficiency 387 tremor was also present. There was severe develop- red cells were determined using a Waters (Millipore- mental retardation, with motor involvement (equal Waters, Harrow, Middlesex, England) trimodule to a child of 1 year) being more severe than fully automated high pressure liquid chromato- intellectual development (equivalent to a child of graphy system coupled to a 5[t APS-Hypersil 2-5 years). The child had started to sit at 1 year and column, or a 5 Spherisorb ODSI column stand at 3 years and walked unsteadily on tiptoe with (25 cm x 4.9 mm, Hichrom, United Kingdom), for help at 3 years 9 months. Investigations showed a the separation of nucleotides, or nucleosides and child with anaemia with a positive result of a direct bases, respectively." 13-15 The method used for Coombs test and severe T cell immunodeficiency.9 determination of PNP activities, as well as the activ- A computed tomogram of the brain and electro- ity of the other purine enzymes-namely, adenosine encephalogram yielded normal results. The child deaminase, adenine phosphoribosyltransferase, and subsequently succumbed to viral infection at the age hypoxanthine-guanine phosphoribosyltransferase of 4 years 6 months. Permission for postmortem (HGPRT)-in lysed red cells using high pressure examination was refused. liquid chromatography, has also been reported.'4 Family history revealed an elder sister (case 4) Studies with 8-[14C] labelled deoxyguanosine, using who had died at 4 years of chickenpox complicated intact red cells, were also carried out to exclude the by pneumonia and carditis and had also been possibility of a labile enzyme detectable only in severely developmentally retarded and suffered intact cells (not lysed cells). They were processed repeated chest and ear infections. (She was con- using a radiodetector (Reeve Analytical, Glasgow, sidered a homozygote for PNP deficiency from the Scotland) coupled to the above high pressure liquid similarity in the case history). An 11 month old chromatography system as previously described.'5 brother (case 5) showed similar abnormalities to the S-adenosylhomocysteine
Load more

Recommended publications
  • P2X7 Receptor Suppression Preserves Blood-Brain Barrier
    www.nature.com/scientificreports OPEN P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation Received: 15 November 2015 Accepted: 03 March 2016 after Experimental Intracerebral Published: 16 March 2016 Hemorrhage in Rats Hengli Zhao1, Xuan Zhang1, Zhiqiang Dai1, Yang Feng1, Qiang Li1, John H. Zhang2, Xin Liu1, Yujie Chen1 & Hua Feng1 Blockading P2X7 receptor(P2X7R) provides neuroprotection toward various neurological disorders, including stroke, traumatic brain injury, and subarachnoid hemorrhage. However, whether and how P2X7 receptor suppression protects blood-brain barrier(BBB) after intracerebral hemorrhage(ICH) remains unexplored. In present study, intrastriatal autologous-blood injection was used to mimic ICH in rats. Selective P2X7R inhibitor A438079, P2X7R agonist BzATP, and P2X7R siRNA were administrated to evaluate the effects of P2X7R suppression. Selective RhoA inhibitor C3 transferase was administered to clarify the involvement of RhoA. Post-assessments, including neurological deficits, Fluoro-Jade C staining, brain edema, Evans blue extravasation and fluorescence, western blot, RhoA activity assay and immunohistochemistry were performed. Then the key results were verified in collagenase induced ICH model. We found that endogenous P2X7R increased at 3 hrs after ICH with peak at 24 hrs, then returned to normal at 72 hrs after ICH. Enhanced immunoreactivity was observed on the neurovascular structure around hematoma at 24 hrs after ICH, along with perivascular astrocytes and endothelial cells. Both A438079 and P2X7R siRNA alleviated neurological deficits, brain edema, and BBB disruption after ICH, in association with RhoA activation and down-regulated endothelial junction proteins. However, BzATP abolished those effects. In addition, C3 transferase reduced brain injury and increased endothelial junction proteins’ expression after ICH.
    [Show full text]
  • Biochemical Differences Among Four Inosinate Dehydrogenase Inhibitors
    [CANCER RESEARCH 45.5512-5520, November 1985] Biochemical Differences among Four Inosinate Dehydrogenase Inhibitors, Mycophenolic Acid, Ribavirin, Tiazofurin, and Selenazofurin, Studied in Mouse Lymphoma Cell Culture1 Huey-Jane Lee, Katarzyna Pawlak, Binh T. Nguyen, Roland K. Robins, and Wolfgang Sadee2 Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, California 94143 [H-J. L, K. P., B. T. N., W. S.], and Cancer Research Center, Department of Chemistry, Brigham Young University, Provo, Utah 84602 [R. K. R.J ABSTRACT 1.2.1.14) catalyzes the conversion of IMP to xanthylate, and it represents a key enzyme in the biosynthesis of guanine nucleo- The mechanism of the cellular toxicity of four ¡nosinatedehy- tides. The activity of IMP dehydrogenase is positively linked to drogenase (IMP-DH) inhibitors with different antitumor and anti cellular transformation and tumor progression; therefore, this viral pharmacological profiles was investigated in mouse lym- enzyme represents a promising target of cancer chemotherapy phoma (S-49) cell culture. Drug effects on cell growth, nucleotide (1-3). Inhibition of IMP dehydrogenase results in the depletion pools, and ÒNA and RNA synthesis were measured in the of cellular guanine nucleotides by blocking their de novo synthe presence and absence of guanine salvage supplies. Both guanine and guanosine were capable of bypassing the IMP-DH block, sis (4). Guanine nucleotides are required as substrates, activa while they also demonstrated some growth-inhibitory
    [Show full text]
  • Deoxyguanosine Cytotoxicity by a Novel Inhibitor of Furine Nucleoside Phosphorylase, 8-Amino-9-Benzylguanine1
    [CANCER RESEARCH 46, 519-523, February 1986] Potentiation of 2'-Deoxyguanosine Cytotoxicity by a Novel Inhibitor of Furine Nucleoside Phosphorylase, 8-Amino-9-benzylguanine1 Donna S. Shewach,2 Ji-Wang Chern, Katherine E. Pillóte,Leroy B. Townsend, and Peter E. Daddona3 Departments of Internal Medicine [D.S.S., P.E.D.], Biological Chemistry [P.E.D.], and Medicinal Chemistry [J-W.C., K.E.P., L.B.T.], University ol Michigan, Ann Arbor, Michigan 48109 ABSTRACT to the ADA-deficient disease state (2). PNP is an essential enzyme of the purine salvage pathway, We have synthesized and evaluated a series of 9-substituted catalyzing the phosphorolysis of guanosine, inosine, and their analogues of 8-aminoguanine, a known inhibitor of human purine 2'-deoxyribonucleoside derivatives to the respective purine nucleoside phosphorylase (PNP) activity. The ability of these bases. To date, several inhibitors of PNP have been identified, agents to inhibit PNP has been investigated. All compounds were and most of these compounds resemble purine bases or nucleo found to act as competitive (with inosine) inhibitors of PNP, with sides. The most potent inhibitors exhibit apparent K¡values in K¡values ranging from 0.2 to 290 /¿M.Themost potent of these the range of 10~6to 10~7 M (9-12). Using partially purified human analogues, 8-amino-9-benzylguanine, exhibited a K, value that erythrocyte PNP, the diphosphate derivative of acyclovir dis was 4-fold lower than that determined for the parent base, 8- played K¡values of 5.1 x 10~7 to 8.7 x 10~9 M, depending on aminoguanine.
    [Show full text]
  • Stimulating Effects of Inosine, Uridine and Glutamine on the Tissue Distribution of Radioactive D-Leucine in Tumor Bearing Mice
    RADIOISOTOPES, 33, 7376 (1984) Note Stimulating Effects of Inosine, Uridine and Glutamine on the Tissue Distribution of Radioactive D-leucine in Tumor Bearing Mice Rensuke GOTO, Atsushi TAKEDA, Osamu TAMEMASA, James E. CHANEY* and George A. DIGENIS* Division of Radiobiochemistry and Radiopharmacology, Shizuoka College of Pharmacy 2-1, Oshika 2-chome, Shizuoka-shi 422, Japan * Division of Medicinal Chemistry and Pharmacognosy , College of Pharmacy, University of Kentucky Lexington, Kentucky 40506, U.S.A. Received September 16, 1983 This experiment was carried out in search for stimulators of the in vivo uptake of D- and L-leucine by tumor and pancreas for the possible application to 7-emitter labeled amino acids in nuclear medical diagnosis. Inosine, uridine, and glutamine which are stimulators of the in vitro incorporation of radioactive L-amino acids into some tumor cells significantly enhanced the uptake of D-leucine into the pancreas, while in Ehrlich solid tumor only a little if any in- crease was observed. Of the compounds tested inosine showed the highest stimulation of pan- creas uptake in the range of doses used, resulting in the best pancreas-to-liver concentration ratio, a factor of significant consideration for pancreas imaging. The uptake of L-leucine by the tumor and pancreas was little affected by these compounds. Key Words: inosine, uridine, glutamine, tissue distribution, radioactive D-leucine, tumor bearing mice, pancreas imaging cine, and L-alanine into Ehrlich or Krebs ascites 1. Introduction carcinoma cells resulting from treatment with High radioactivity uptake of some radioactive inosine, uridine, or glutamine. These findings D-amino acids by the tumor and pancreas of suggest that these compounds might bring about tumor-bearing animalsl' '2) or by the pancreas of the increased in vivo uptake of amino acids.
    [Show full text]
  • 2'-Deoxyguanosine Toxicity for B and Mature T Lymphoid Cell Lines Is Mediated by Guanine Ribonucleotide Accumulation
    2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Y Sidi, B S Mitchell J Clin Invest. 1984;74(5):1640-1648. https://doi.org/10.1172/JCI111580. Research Article Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8- aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'- deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine.
    [Show full text]
  • We Have Previously Reported' the Isolation of Guanosine Diphosphate
    VOL. 48, 1962 BIOCHEMISTRY: HEATH AND ELBEIN 1209 9 Ramel, A., E. Stellwagen, and H. K. Schachman, Federation Proc., 20, 387 (1961). 10 Markus, G., A. L. Grossberg, and D. Pressman, Arch. Biochem. Biophys., 96, 63 (1962). "1 For preparation of anti-Xp antisera, see Nisonoff, A., and D. Pressman, J. Immunol., 80, 417 (1958) and idem., 83, 138 (1959). 12 For preparation of anti-Ap antisera, see Grossberg, A. L., and D. Pressman, J. Am. Chem. Soc., 82, 5478 (1960). 13 For preparation of anti-Rp antisera, see Pressman, D. and L. A. Sternberger, J. Immunol., 66, 609 (1951), and Grossberg, A. L., G. Radzimski, and D. Pressman, Biochemistry, 1, 391 (1962). 14 Smithies, O., Biochem. J., 71, 585 (1959). 15 Poulik, M. D., Biochim. et Biophysica Acta., 44, 390 (1960). 16 Edelman, G. M., and M. D. Poulik, J. Exp. Med., 113, 861 (1961). 17 Breinl, F., and F. Haurowitz, Z. Physiol. Chem., 192, 45 (1930). 18 Pauling, L., J. Am. Chem. Soc., 62, 2643 (1940). 19 Pressman, D., and 0. Roholt, these PROCEEDINGS, 47, 1606 (1961). THE ENZYMATIC SYNTHESIS OF GUANOSINE DIPHOSPHATE COLITOSE BY A MUTANT STRAIN OF ESCHERICHIA COLI* BY EDWARD C. HEATHt AND ALAN D. ELBEINT RACKHAM ARTHRITIS RESEARCH UNIT AND DEPARTMENT OF BACTERIOLOGY, THE UNIVERSITY OF MICHIGAN Communicated by J. L. Oncley, May 10, 1962 We have previously reported' the isolation of guanosine diphosphate colitose (GDP-colitose* GDP-3,6-dideoxy-L-galactose) from Escherichia coli 0111-B4; only 2.5 umoles of this sugar nucleotide were isolated from 1 kilogram of cells. Studies on the biosynthesis of colitose with extracts of this organism indicated that GDP-mannose was a precursor;2 however, the enzymatically formed colitose was isolated from a high-molecular weight substance and attempts to isolate the sus- pected intermediate, GDP-colitose, were unsuccessful.
    [Show full text]
  • Isolation and Analysis of Sugar Nucleotides Using Solid Phase Extraction and fluorophore Assisted Carbohydrate Electrophoresis
    MethodsX 3 (2016) 251–260 Contents lists available at ScienceDirect MethodsX journal homepage: www.elsevier.com/locate/mex Isolation and analysis of sugar nucleotides using solid phase extraction and fluorophore assisted carbohydrate electrophoresis Jarrod Barnesa,1, Liping Tiana,1, Jacqueline Loftisa, James Hiznayc, Suzy Comhaira, Mark Lauera,2, Raed Dweika,b,* a Departments of Pathobiology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA b Pulmonary Critical Care Medicine, Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA c Molecular Medicine, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA GRAPHICAL ABSTRACT ABSTRACT The building blocks of simple and complex oligosaccharides, termed sugar nucleotides, are often overlooked for their role in metabolic diseases and may hold the key to the underlying disease pathogenesis. Multiple reasons may account for the lack of analysis and quantitation of these sugar nucleotides, including the difficulty in isolation and purification as well as the required expensive instrumentation such as a high performance liquid Abbreviations: HPLC, high performance liquid chromatography; SPE, solid phase extraction; FACE, fluorophore assisted carbohydrate electrophoresis; UDP, uridine diphosphate; GDP, guanosine diphosphate; CMP, cytosine monophosphate; TEAA, triethylamine acetate; APS, ammonium persulfate; Gal, galactose; GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylgluco- samine; Man, Mannose; NeuAc, sialic acid; GlcUA, glucuronic acid; AMAC, 2-aminoacridone; TEMED, N0,N0,N0N0- tetramethylenediamine. * Corresponding author at: Departments of Pathobiology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, Ohio 44195, USA. E-mail address: [email protected] (R. Dweik). 1 Authors contributed equally to this work. 2 In honor of Dr. Mark Lauer who passed away October 12, 2015. http://dx.doi.org/10.1016/j.mex.2016.03.010 2215-0161/ ã 2016 The Authors.
    [Show full text]
  • Human Hypoxanthine (Guanine) Phosphoribosyltransferase: An
    Proc. NatL Acad. Sci. USA Vol. 80, pp. 870-873, Febriary 1983 Medical Sciences Human hypoxanthine (guanine) phosphoribosyltransferase: An amino acid substitution in a mutant form of the enzyme isolated from a patient with gout (reverse-phase HPLC/peptide mapping/mutant enzyme) JAMES M. WILSON*t, GEORGE E. TARRt, AND WILLIAM N. KELLEY*t Departments of *Internal Medicine and tBiological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109 Communicated by James B. Wyngaarden, November 3, 1982 ABSTRACT We have investigated the molecular basis for a tration ofenzyme protein. in both erythrocytes (3) and lympho- deficiency ofthe enzyme hypoxanthine (guanine) phosphoribosyl- blasts (4); (ii) a normal Vm., a normal Km for 5-phosphoribosyl- transferase (HPRT; IMP:pyrophosphate-phosphoribosyltransfer- 1-pyrophosphate, and a 5-fold increased Km for hypoxanthine ase, EC 2.4.2.8) in a patient with a severe form of gout. We re-. (unpublished data); (iii) a normal isoelectric point (3, 4) and ported in previous studies the isolation of a unique structural migration during nondenaturing polyacrylamide gel electro- variant of HPRT from this patient's erythrocytes and cultured phoresis (4); and (iv) -an apparently smaller subunit molecular lymphoblasts. This enzyme variant, which is called HPRTOnd0., weight as evidenced by an increased mobility during Na- is characterized by a decreased concentration of HPRT protein DodSO4/polyacrylamide gel electrophoresis (3, 4). in erythrocytes and lymphoblasts, a normal Vm.., a 5-fold in- Our study ofthe tryptic peptides and amino acid composition creased Km for hypoxanthine, a normal isoelectric point, and an of apparently smaller subunit molecular weight. Comparative pep- HPRTLondon revealed a single amino acid substitution (Ser tide mapping-experiments revealed a single abnormal tryptic pep- Leu) at position 109.
    [Show full text]
  • A New Crystal Form of Bovine Pancreatic Rnase a in Complex with 2
    protein structure communications Acta Crystallographica Section F Structural Biology A new crystal form of bovine pancreatic RNase A in 000 and Crystallization complex with 2 -deoxyguanosine- Communications 5000-monophosphate ISSN 1744-3091 Steven B. Larson,a John S. Day,a The structure of bovine pancreatic RNase A has been determined in complex Robert Cudneyb and Alexander with 20-deoxyguanosine-50-monophosphate (dGMP) at 1.33 A˚ resolution at McPhersona* room temperature in a previously unreported unit cell belonging to space group P31. There are two molecules of nucleotide per enzyme molecule, one of which aDepartment of Molecular Biology and lies in the active-site cleft in the productive binding mode, whilst the guanine Biochemistry, The University of California, base of the other dGMP occupies the pyrimidine-specific binding site in a Irvine, CA 92697-3900, USA, and bHampton nonproductive mode such that it forms hydrogen bonds to the phosphate group Research, Aliso Viejo, CA 92656-3317, USA of the first dGMP. This is the first RNase A structure containing a guanine base in the B2 binding site. Each dGMP molecule is involved in intermolecular interactions with adjacent RNase A molecules in the lattice and the two Correspondence e-mail: [email protected] nucleotides appear to direct the formation of the crystal lattice. Because GMP may be produced during degradation of RNA, this association could represent Received 19 June 2007 an inhibitor complex and thereby affect the observed enzyme kinetics. Accepted 9 August 2007 PDB Reference: RNase A–dGMP complex, 2qca, r2qcasf. 1. Introduction Bovine pancreatic ribonuclease (EC 3.1.27.5), commonly known as RNase A, has been extensively studied by physical-chemical approaches and by X-ray crystallography for nearly 75 years.
    [Show full text]
  • Synthesis and Biological Evaluation of Purine and Pyrimidine Based Ligands for the A3 and the P2Y2 Purinergic Receptors
    Synthesis and Biological Evaluation of Purine and Pyrimidine Based Ligands for the A3 and the P2Y2 Purinergic Receptors Apr. Liesbet Cosyn Thesis submitted to the Faculty of Pharmaceutical Sciences to obtain the degree of Doctor in Pharmaceutical Sciences Promoter Prof. dr. apr. Serge Van Calenbergh Academic year 2007-2008 TABLE OF CONTENTS 1 INTRODUCTION ................................................................................................. 3 1.1 Purinergic Receptors ................................................................................. 3 1.2 Adenosine Analogues and the Adenosine A3 Receptor ......................... 4 1.2.1 Adenosine................................................................................................. 4 1.2.2 The Adenosine Receptors: G-protein-Coupled Receptors........................ 7 1.2.3 Adenosine Receptor Subtypes and Their Signalling............................... 10 1.2.4 The Adenosine A3 Receptor ................................................................... 12 1.2.4.1 Adenosine A3 Receptor Agonists ................................................. 12 1.2.4.2 Adenosine A3 Receptor Antagonists ............................................ 16 1.2.4.3 Allosteric Modulation.................................................................... 21 1.2.4.4 Molecular Modeling of the Adenosine A3 Receptor...................... 22 1.2.4.5 The Neoceptor concept................................................................ 23 1.2.4.6 Therapeutic Potential of A3AR Agonists......................................
    [Show full text]
  • Reversibility Ofthe Pyrophosphoryl Transfer from ATP to GTP By
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 9, pp. 3470-3473, September 1974 Reversibility of the Pyrophosphoryl Transfer from ATP to GTP by Escherichia coli Stringent Factor (guanosine 5'-diphosphate-3'-diphosphate/guanosine 5'-triphosphate-3'-diphosphate/relaxed control/ribosomes) JOSE SY The Rockefeller University, New York, N.Y. 10021 Communicated by Fritz Lipmann, July 1, 1974 ABSTRACT The stringent factor-catalyzed, ribosome- was incubated for 60 min at 300 in a 1W0-1 mixture contain- dependent synthesis of guanosine polyplosphates is ing: 50 mM Tris OAc, pH 8.1; 4 mM dithiothreitol; 20 mM found to be reversible. The reverse reaction specifically requires 5'-AMP as the pyrophosphoryl acceptor, and Mg(OAc)2; 5 mM ATP; 10 ,ug of poly(A, U, G); 27 pgof tRNA; guanosine 5'-triphosphate-3'-diphospbate is preferentially 90',g of ethanol-washed ribosomes; and 2 p&g of fraction II utilized as the pyrophosphoryl donor. The primary prod- stringent factor. By minimizing GTPase activity with the ucts of the reaction are GTP and ANP. The reverse reaction use of high Mg++ concentration and ethanol-washed ribo- is strongly inhibited by the antibiotics thiostrepton and a ob- tetracycline, and b' A P and,1-y-pnethylene-adenosixie- somes with a minimal time of incubation, product is triphosphate, but not by ADP, GTP, and GIDP. The reverse tained that is more than 95% pppGpp. After incubation, 1 Al reaction occurs under conditions for nonribosomal syn- of 88% HCOOH was added and the resulting precipitate dis- thesis. The ove'rill reaction for stringent factor-catalyzed carded.
    [Show full text]
  • Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation
    Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. X Jin, … , B R Duling, J Linden J Clin Invest. 1997;100(11):2849-2857. https://doi.org/10.1172/JCI119833. Research Article We investigated the mechanism by which inosine, a metabolite of adenosine that accumulates to > 1 mM levels in ischemic tissues, triggers mast cell degranulation. Inosine was found to do the following: (a) compete for [125I]N6- aminobenzyladenosine binding to recombinant rat A3 adenosine receptors (A3AR) with an IC50 of 25+/-6 microM; (b) not bind to A1 or A2A ARs; (c) bind to newly identified A3ARs in guinea pig lung (IC50 = 15+/-4 microM); (d) lower cyclic AMP in HEK-293 cells expressing rat A3ARs (ED50 = 12+/-5 microM); (e) stimulate RBL-2H3 rat mast-like cell degranulation (ED50 = 2.3+/-0.9 microM); and (f) cause mast cell-dependent constriction of hamster cheek pouch arterioles that is attenuated by A3AR blockade. Inosine differs from adenosine in not activating A2AARs that dilate vascular smooth muscle and inhibit mast cell degranulation. The A3 selectivity of inosine may explain why it elicits a monophasic arteriolar constrictor response distinct from the multiphasic dilator/constrictor response to adenosine. Nucleoside accumulation and an increase in the ratio of inosine to adenosine may provide a physiologic stimulus for mast cell degranulation in ischemic or inflamed tissues. Find the latest version: https://jci.me/119833/pdf Inosine Binds to A3 Adenosine Receptors and Stimulates Mast Cell Degranulation Xiaowei Jin,* Rebecca K. Shepherd,‡ Brian R. Duling,‡ and Joel Linden‡§ *Department of Biochemistry, ‡Department of Molecular Physiology and Biological Physics, and §Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908 Abstract Mast cells are found in the lung where they release media- tors that constrict bronchiolar smooth muscle.
    [Show full text]